1. Home
  2. CDXS vs PMM Comparison

CDXS vs PMM Comparison

Compare CDXS & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • PMM
  • Stock Information
  • Founded
  • CDXS 2002
  • PMM 1989
  • Country
  • CDXS United States
  • PMM United States
  • Employees
  • CDXS N/A
  • PMM N/A
  • Industry
  • CDXS Major Chemicals
  • PMM Investment Managers
  • Sector
  • CDXS Industrials
  • PMM Finance
  • Exchange
  • CDXS Nasdaq
  • PMM Nasdaq
  • Market Cap
  • CDXS 254.3M
  • PMM 251.7M
  • IPO Year
  • CDXS 2010
  • PMM N/A
  • Fundamental
  • Price
  • CDXS $2.44
  • PMM $6.12
  • Analyst Decision
  • CDXS Buy
  • PMM
  • Analyst Count
  • CDXS 2
  • PMM 0
  • Target Price
  • CDXS $11.00
  • PMM N/A
  • AVG Volume (30 Days)
  • CDXS 1.1M
  • PMM 118.3K
  • Earning Date
  • CDXS 10-30-2025
  • PMM 01-01-0001
  • Dividend Yield
  • CDXS N/A
  • PMM 4.68%
  • EPS Growth
  • CDXS N/A
  • PMM N/A
  • EPS
  • CDXS N/A
  • PMM 0.23
  • Revenue
  • CDXS $57,164,000.00
  • PMM N/A
  • Revenue This Year
  • CDXS $12.88
  • PMM N/A
  • Revenue Next Year
  • CDXS $21.64
  • PMM N/A
  • P/E Ratio
  • CDXS N/A
  • PMM $26.52
  • Revenue Growth
  • CDXS N/A
  • PMM N/A
  • 52 Week Low
  • CDXS $1.90
  • PMM $5.00
  • 52 Week High
  • CDXS $6.08
  • PMM $6.42
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 37.30
  • PMM 74.14
  • Support Level
  • CDXS $2.37
  • PMM $6.04
  • Resistance Level
  • CDXS $2.54
  • PMM $5.87
  • Average True Range (ATR)
  • CDXS 0.12
  • PMM 0.05
  • MACD
  • CDXS -0.01
  • PMM 0.03
  • Stochastic Oscillator
  • CDXS 30.00
  • PMM 100.00

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: